Requesting UHN Materials
Research materials developed at UHN are transferred to non-profit research institutes with a Material Transfer Agreement (MTA) in place.
MTAs are important because they:
- Establish terms for the use of research materials.
- Monitor users and deter unauthorized transfer of materials to third parties.
- Regulate ownership of further intellectual property generated from use of the material.
- Warn about the use of material and have users assume liabilities for their use of the material.
Any request for materials should be submitted directly to our office at:

Material will be sent based on availability and consent of the UHN investigator.
Biological Material Transfer Agreement
Biological Material Transfer Agreement - Tsao
Tissue Transfer Agreement
Clinical Trial Tissue Transfer Agreement
Note: These templates are not applicable for for-profit institutes/companies. Please contact the the TDC office at tdc@uhnresearch.ca for more information. |
Accessing UHN Confidential Information
Research Institutes and Companies that wishes to discuss with a UHN investigator his/her work, should contact the TDC office to prepare and execute a Confidential Disclosure Agreement (CDA) on behalf of UHN.
CDAs are important because they:
- Establish terms for sharing confidential materials, knowledge, or information in order to protect disclosure of any type of proprietary information.
- Outline the scope of the confidential information that the parties wish to share.
- Protect patentability.
UHN's standard CDA ensures that disclosures in either direction, intended or otherwise, are covered by confidentiality.
Mutual Confidential Disclosure Agreement |
Forms
UHN Invention Disclosure Form
Biological Material Transfer Agreement
Biological Material Transfer Agreement - Tsao
Tissue Transfer Agreement
Clinical Trial Tissue Transfer Agreement
|
Frequently Asked Questions
I'm about to publish a paper on a novel discovery, what do I need to do to protect my ideas?
I have been contacted by a company requesting my material, what next?
And more... |